Biocitech life science park welcomes Pherecydes Pharma

Published: 8-Oct-2008

Biosecurity and biodefence business Pherecydes Pharma S.A. has become the latest company to join Biocitech – the Paris life science technology park.


The company joins 21 other resident companies on Biocitech’s campus and boosts the park's occupancy rate to 93%.

The company is developing innovative biopharmaceutical solutions to threats from bacteria as well as therapeutic and identification tools based on phage technology. It also offers biosensors for the real time identification of bacteria and solutions for surface decontamination. Pherecydes Pharma is a spin-off from the research activities of Bio-Modeling Systems SAS, a predictive integrative biology specialist.

‘Anti-infectious research has always been part of the culture and history of the Biocitech site,’ said Biocitech ceo Jacques Lhomel. ‘We are really pleased to welcome Pherecydes Pharma as its activities are complementary to and will strengthen the anti-infectious research network already present at Biocitech. Its arrival will be a source of new inter-company synergies, one of the key concepts driving the development of the park.’

‘We chose Biocitech for three reasons: its nearness to Paris, the quality of the accommodation and the services it offers,’ said Manuel Géa, co-founder of Pherecydes Pharma and ceo of Bio-Modeling Systems. ‘It is a technology park with very comprehensive facilities and is especially suited to start-ups. Biocitech was the only technology park we found able to support the rapid development of Pherecydes Pharma. And we knew that the site had a ready-made network of anti-infectious focused companies which will allow us to develop strategic collaborations.’

Biocitech is privately-owned and provides secure premises and comprehensive facilities based on the latest technology. It has received regulatory approval for conformity to environmental protection standards. Companies can use one or many of the services offered. These include offices, laboratories and a range of technical and scientific services – all designed to let entrepreneurs concentrate their time and resources on their core business.

Companies already established at Biocitech represent a wide variety of complementary disciplines and many are working on collaborative projects.

You may also like